617 F. Supp. 1521 - McCormack v. Abbott Laboratories’s Empirical Analysis
1985
Citation profile
2 federal appellate · 5 district · 11 state decisions
How this case has been cited
Cited by 18 later decisions — most recently October 2013
2 federal appellate · 5 district · 11 state decisions
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Relies on 26 Cal. 3d 588 - Sindell v. Abbott Laboratories · 8 Cal. 3d 121 - Cronin v. J.B.E. Olson Corp. · 33 Cal. 2d 80 - Summers v. Tice · Payton v. Abbott Labs · 116 Wis. 2d 166 - Collins v. Eli Lilly & Co.
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 18 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“some relaxation of the traditional identification requirement in appropriate circumstances so as to allow recovery against a negligent defendant of that portion of a plaintiff’s damages which is represented by that defendant’s contribution of DES to the market in the relevant period of time.”
1 later decision quote this exact passage · from the majority“the magnitude of the physical and psychological injuries which are at issue in DES cases counsels toward permitting a remedy under some form of a market-share theory of liability.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.